Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 7/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574618 | 0.98 | TSHR (0.63) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| Water SCHEMBL19915275 | 0.96 | TSHR (0.61) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL734992 | 0.96 | TSHR (0.61) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL28540211 | 0.96 | TSHR (0.61) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL679492 | 0.84 | TSHR (0.50) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL16598169 | 0.80 | LMNA (0.63) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL10203414 | 0.79 | LMNA (0.68) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL3908136 | 0.79 | LMNA (0.68) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| SCHEMBL29525350 | 0.79 | LMNA (0.68) | TSHRLMNAHPGDHSD17B10ALOX15 | |
| Salicylic Acid SCHEMBL8206603 | 0.79 | ALDH1A1 (0.58) | TSHRLMNAHPGDHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122859-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | NOKHA TRADING LLP (IN) | 2024-04-18 | — | — | US | claimed |
| WO-2022172225-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | LYRUS LIFE SCIENCES PVT. LTD. (IN) | 2022-08-18 | — | — | WO | claimed |
| US-20200054045-A1 | All-Natural Drink Composition for Synthesizing and Regenerating Adenosine Triphosphate (ATP) in Muscle Cells and Neurons, Repairing Exercise-Induced Muscle Fiber Damage, Repletion of Glycogen Stores in the Muscle and Liver, Enhancing Blood Flow to Tissue during Intense Exercise, and Preventing and Reducing Oxidative Damage to Tissues during Exercise with Minimal Gastrointestinal Disturbances | BIOMECHANICAL TECH LLC (US) | 2020-02-20 | — | — | US | claimed |
| CN-106473847-A | The dilatancy local urinary tract intracavity stent system of degradable | 曹庆杰 | 2017-03-08 | — | — | CN | claimed |
| US-8137712-B2 | Rehydration beverage | Hays, Evan (US) | 2012-03-20 | — | — | US | claimed |
| US-20100183736-A1 | REHYDRATION BEVERAGE | HAYS EVAN | 2010-07-22 | — | — | US | claimed |
| WO-2008021861-A2 | REHYDRATION BEVERAGE | HAYS EVAN (US) | 2008-02-21 | — | — | WO | claimed |
| EP-1599190-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | Glenmark Pharmaceuticals Limited (IN) | 2005-11-30 | — | — | EP | claimed |
| CN-1226295-C | Synthesis of Important intermediate for mosapride citrate | LUNAN PHARM CO LTD (CN) | 2005-11-09 | — | — | CN | claimed |
| US-20050095271-A1 | Electrolyte Energy Gel | CRANK SPORTS, INC. (US) | 2005-05-05 | — | — | US | claimed |
| US-20040185097-A1 | Controlled release modifying complex and pharmaceutical compositions thereof | GLENMARK PHARMACEUTICALS LTD. | 2004-09-23 | — | — | US | claimed |
| WO-2004066910-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-12 | — | — | WO | claimed |
| EP-1161249-A4 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LAB INC (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030064135-A1 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PORTMAN ROBERT (US) | 2003-04-03 | — | — | US | claimed |
| US-20020197352-A1 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PACIFICHEALTH LABORATORIES, INC. | 2002-12-26 | — | — | US | claimed |
| EP-1161249-A1 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | Pacifichealth Laboratories, Inc. (US) | 2001-12-12 | — | — | EP | claimed |
| WO-2000027408-A9 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LAB INC (US) | 2000-09-21 | — | — | WO | claimed |
| WO-2000027408-A1 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LABORATORIES, INC. (US) | 2000-05-18 | — | — | WO | claimed |
| US-6051236-A | NUTRITIONAL COMPOSITION IN A DRY POWDER FORM FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE AND FOR ENHANCING MUSCLE CELL REPAIR AND RECOVERY FOLLOWING THE CESSATION OF EXERCISE | PACIFICHEALTH LABORATORIES, INC. (US) | 2000-04-18 | — | — | US | claimed |
| EP-4082552-B1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2026-05-06 | — | — | EP | disclosed |
| CN-119877049-A | Electroplating additive solution, preparation method thereof and hard silver graphene electroplating mixed solution | 温州泰钰新材料科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20240122859-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | NOKHA TRADING LLP (IN) | 2024-04-18 | — | — | US | disclosed |
| US-11491184-B2 | Liquids rich in noble gas and methods of their preparation and use | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-11-08 | — | — | US | disclosed |
| EP-4082552-A1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | The Board of Regents of the University of Texas System (US) | 2022-11-02 | — | — | EP | disclosed |
| WO-2022172225-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | LYRUS LIFE SCIENCES PVT. LTD. (IN) | 2022-08-18 | — | — | WO | disclosed |
| US-20220169680-A1 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2022-06-02 | — | — | US | disclosed |
| CN-111807749-B | Hexavalent chromium reducing agent and preparation method thereof | 内蒙古同佳技术发展有限公司 | 2022-04-12 | — | — | CN | disclosed |
| EP-2968126-B1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2022-04-06 | — | — | EP | disclosed |
| CN-215490927-U | To amino sodium salicylate production with circulation drying device | 德兴市宏达塑胶科技有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-215490927-U | To amino sodium salicylate production with circulation drying device | 德兴市宏达塑胶科技有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-111807749-A | Hexavalent chromium reducing agent and preparation method thereof | 内蒙古同佳技术发展有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-20200215100-A1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2020-07-09 | — | — | US | disclosed |
| US-20200054045-A1 | All-Natural Drink Composition for Synthesizing and Regenerating Adenosine Triphosphate (ATP) in Muscle Cells and Neurons, Repairing Exercise-Induced Muscle Fiber Damage, Repletion of Glycogen Stores in the Muscle and Liver, Enhancing Blood Flow to Tissue during Intense Exercise, and Preventing and Reducing Oxidative Damage to Tissues during Exercise with Minimal Gastrointestinal Disturbances | BIOMECHANICAL TECH LLC (US) | 2020-02-20 | — | — | US | disclosed |
| CN-109432152-A | A kind of Herba seu Radix Cirsii Japonici and its preparation method and application | 四川师范大学 | 2019-03-08 | — | — | CN | disclosed |
| CN-106758158-B | A kind of environmental protection weaving refining agent and preparation method thereof for mulberry silk | 吴江市北厍盛源纺织品助剂厂 | 2019-03-01 | — | — | CN | disclosed |
| US-20180271897-A1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2018-09-27 | — | — | US | disclosed |
| CN-104324143-B | It is a kind of to treat scrofulous Chinese medicine composition | 宋群库 | 2018-08-10 | — | — | CN | disclosed |
| CN-108283679-A | It is a kind of to treat scrofulous Tujia's drug | 熊鑫 | 2018-07-17 | — | — | CN | disclosed |
| US-20160030470-A1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2016-02-04 | — | — | US | disclosed |
| EP-2968126-A2 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | The Board of Regents of The University of Texas System (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-101538217-B | Novel synthesis method of 2-ethoxy-4-amino-5-chlorobenzoic acid and intermediate thereof | CHENGDU HONGDA PHARMACEUTICAL CO LTD | 2015-04-15 | — | — | CN | disclosed |
| WO-2014145443-A2 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014028122-A1 | EXERCISE DRINK COMPOSITION | SPORTSFUEL, INC. (US) | 2014-02-20 | — | — | WO | disclosed |
| CN-103396334-A | New synthesis method of 2-ethoxy-4-amino-5-chlorobenzoic acid and intermediate thereof | CHENGDU HONGDA PHARMACEUTICAL CO LTD | 2013-11-20 | — | — | CN | disclosed |
| US-8137712-B2 | Rehydration beverage | Hays, Evan (US) | 2012-03-20 | — | — | US | disclosed |
| EP-1663253-B1 | FORMULATIONS CONTAINING SALICYLATES AND THEIR USE FOR TREATING INFLAMMATORY BOWEL DISEASE | AGI THERAPEUTICS RES LTD (IE) | 2010-12-01 | — | — | EP | disclosed |
| US-20100183736-A1 | REHYDRATION BEVERAGE | HAYS EVAN | 2010-07-22 | — | — | US | disclosed |
| US-20100150996-A1 | ATHLETIC PATCH | VITA-PATCH LLC (US) | 2010-06-17 | — | — | US | disclosed |
| EP-2123267-A1 | Novel compositions and methods for treating hyperproliferative diseases | Chen, Chien-Hung (US) | 2009-11-25 | — | — | EP | disclosed |
| CN-101538217-A | Novel synthesis method of 2-ethoxy-4-amino-5-chlorobenzoic acid and intermediate thereof | CHENGDU KANGHONG PHARMACEUTICA | 2009-09-23 | — | — | CN | disclosed |
| EP-1363716-B1 | METHOD OF CLARIFYING BAYER PROCESS LIQUORS USING SALICYLIC ACID CONTAINING POLYMERS | ONDEO NALCO CO (US) | 2008-10-15 | — | — | EP | disclosed |
| WO-2008021861-A2 | REHYDRATION BEVERAGE | HAYS EVAN (US) | 2008-02-21 | — | — | WO | disclosed |
| US-7138472-B2 | High molecular weight polymers containing pendant salicylic acid groups for clarifying bayer process liquors | NALCO COMPANY (US) | 2006-11-21 | — | — | US | disclosed |
| US-20060121172-A1 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PACIFICHEALTH LABORATORIES, INC. | 2006-06-08 | — | — | US | disclosed |
| EP-1597301-A4 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDENT SALICYCLIC ACID GROUPS FOR CLARIFYING BAYER PROCESS LIQUORS | NALCO CO (US) | 2006-05-17 | — | — | EP | disclosed |
| US-6989171-B2 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PACIFICHEALTH LABORATORIES, INC. (US) | 2006-01-24 | — | — | US | disclosed |
| EP-1599190-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | Glenmark Pharmaceuticals Limited (IN) | 2005-11-30 | — | — | EP | disclosed |
| EP-1597301-A2 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDENT SALICYCLIC ACID GROUPS FOR CLARIFYING BAYER PROCESS LIQUORS | Nalco Company (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050249793-A1 | Athletic patch | VITA-PATCH LLC (US) | 2005-11-10 | — | — | US | disclosed |
| CN-1226295-C | Synthesis of Important intermediate for mosapride citrate | LUNAN PHARM CO LTD (CN) | 2005-11-09 | — | — | CN | disclosed |
| US-6893656-B2 | Administering nutrients during exercise; topical applying to skin | VITA-PATCH, LLC (US) | 2005-05-17 | — | — | US | disclosed |
| EP-1363716-A4 | METHOD OF CLARIFYING BAYER PROCESS LIQUORS USING SALICYLIC ACID CONTAINING POLYMERS | ONDEO NALCO CO (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20040185097-A1 | Controlled release modifying complex and pharmaceutical compositions thereof | GLENMARK PHARMACEUTICALS LTD. | 2004-09-23 | — | — | US | disclosed |
| WO-2004076510-A2 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDENT SALICYCLIC ACID GROUPS FOR CLARIFYING BAYER PROCESS LIQUORS | NALCO COMPANY (US) | 2004-09-10 | — | — | WO | disclosed |
| CN-1526700-A | Synthesis of Important intermediate for mosapride citrate | 鲁南制药股份有限公司 | 2004-09-08 | — | — | CN | disclosed |
| WO-2004066910-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-12 | — | — | WO | disclosed |
| EP-1368390-A4 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDANT SALICYLIC ACID GROUPS | ONDEO NALCO CO (US) | 2004-08-11 | — | — | EP | disclosed |
| US-20040024156-A1 | High molecular weight polymers containing pendant salicylic acid groups for clarifying bayer process liquors | ECOLAB USA INC. | 2004-02-05 | — | — | US | disclosed |
| EP-1368390-A1 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDANT SALICYLIC ACID GROUPS | Ondeo Nalco Company (US) | 2003-12-10 | — | — | EP | disclosed |
| EP-1363716-A1 | METHOD OF CLARIFYING BAYER PROCESS LIQUORS USING SALICYLIC ACID CONTAINING POLYMERS | Ondeo Nalco Company (US) | 2003-11-26 | — | — | EP | disclosed |
| EP-1161249-A4 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LAB INC (US) | 2003-05-21 | — | — | EP | disclosed |
| US-20030064135-A1 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PORTMAN ROBERT (US) | 2003-04-03 | — | — | US | disclosed |
| US-20030054026-A1 | Athletic patch | VITA-PATCH, LLC | 2003-03-20 | — | — | US | disclosed |
| US-20020197352-A1 | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise | PACIFICHEALTH LABORATORIES, INC. | 2002-12-26 | — | — | US | disclosed |
| US-6475514-B1 | Athletic patch | VITA-PATCH, LLC | 2002-11-05 | — | — | US | disclosed |
| WO-2002060966-A1 | HIGH MOLECULAR WEIGHT POLYMERS CONTAINING PENDANT SALICYLIC ACID GROUPS | ONDEO NALCO COMPANY (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002060555-A1 | METHOD OF CLARIFYING BAYER PROCESS LIQUORS USING SALICYLIC ACID CONTAINING POLYMERS | ONDEO NALCO COMPANY (US) | 2002-08-08 | — | — | WO | disclosed |
| EP-1161249-A1 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | Pacifichealth Laboratories, Inc. (US) | 2001-12-12 | — | — | EP | disclosed |
| WO-2000027408-A9 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LAB INC (US) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000027408-A1 | COMPOSITION FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE | PACIFICHEALTH LABORATORIES, INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| US-6051236-A | NUTRITIONAL COMPOSITION IN A DRY POWDER FORM FOR OPTIMIZING MUSCLE PERFORMANCE DURING EXERCISE AND FOR ENHANCING MUSCLE CELL REPAIR AND RECOVERY FOLLOWING THE CESSATION OF EXERCISE | PACIFICHEALTH LABORATORIES, INC. (US) | 2000-04-18 | — | — | US | disclosed |
| EP-0681434-B1 | REHYDRATION DRINK | SIMONE CHARLES B (US) | 1996-10-02 | — | — | EP | disclosed |
| US-5397786-A | Rehydration drink | SIMONE CHARLES B (US) | 1995-03-14 | — | — | US | disclosed |
| WO-1994015488-A2 | REHYDRATION DRINK | TECHNOLIZENZ ETS (LI) | 1994-07-21 | — | — | WO | disclosed |
| CN-1037837-A | Prescription of stone-removing ointment and its preparation method | HE DIANAI (CN) | 1989-12-13 | — | — | CN | disclosed |
| CN-1037837-A | Prescription of stone-removing ointment and its preparation method | HE DIANAI (CN) | 1989-12-13 | — | — | CN | disclosed |